The Latest Cardiac and Vascular News
Proxy allows for seamless data transmission and improved AI-based plaque analysis NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced a new workflow solution to its portfolio, Proxy. Cleerly Proxy is a software that […]
Hire follows Cleerly’s $223 million Series C and furthers value-based care business strategy NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced it has appointed Joseph “Joe” Jasser, MD, as chief of value based […]
This press release was updated on July 28, 2022 to reflect that Cleerly secured additional Series C funding, raising its round total from $192 million to $223 million. Updated July 28, 2022: New York – July 25, 2022 — Cleerly, the company […]
April 20, 2022 New research proposes a four-stage system for measuring the progression of cardiovascular disease (CAD) based on atherosclerotic plaque – not secondary symptoms of heart disease. Quantification of CAD burden and plaque type has demonstrated to be the […]
Findings from Cleerly’s groundbreaking CLARIFY 2 study echo the recent American College of Cardiology guidelines on the use of CCTA for non-invasive heart disease evaluation. The study, the second of six studies comparing Cleerly analysis against current gold standards to plaque and coronary artery […]
Cleerly 2.2.0 includes UX updates and three high-value tools to better evaluate heart disease NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced its latest product release, Cleerly 2.2.0, that includes user experience (UX) […]
Organization recognizes the most promising and innovative health startups in New York NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced that New York City Health Business Leaders (NYCHBL), the organization that serves as the gateway […]
NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced today it has expanded its board of directors with three new medical and investment leaders. Kevin M. King, Glenn D. Steele Jr., MD, PhD and […]
Sales strategy expert brings industry success to leverage growth. NEW YORK – October 18, 2021 – Cleerly, the company creating a new standard of care for heart disease, announced today it has appointed Jim Hartman as Chief Revenue Officer. In […]
Brandon Atkinson joins as COO and Nick Nieslanik as CTO to Support Company’s Mission to Create a New Standard of Care for Heart Disease, the Leading Cause of Death. NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care […]
